At a glance
ClinicalIndex Comparison RecordN/ARecruiting· 100 target
Drug / intervention
WMTother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Washed Microbiota Transplantation for Clostridioides Difficile Infection: a Real World Research
The Second Hospital of Nanjing Medical University·observational·Posted Oct 30, 2023·Updated Oct 30, 2023
In Brief
An observational study evaluating WMT for Clostridioides Difficile Infection. Currently recruiting, targeting 100 participants across 1 site.
Detailed Summary
This is a real-world study to explore the safety and the efficacy of washed microbiota transplantation （WMT） for patients with Clostridioides Difficile Infection （CDI）.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsClostridioides Difficile Infection
CountriesChina
Collaborators--
Timeline
N/ARecruiting
2024202520262027202820292030
Enrollment StartJul 2023
First PostedOct 2023
TodayJul 2026
Primary CompletionJul 2029
Study CompletionDec 2029
First PostedOct 30, 2023
Enrollment StartJul 22, 2023
Primary CompletionJul 1, 2029
Study CompletionDec 1, 2029
TodayJul 1, 2026
Enrollment to primary: 5.9 yearsPosted 2.7 years agoPrimary completion in 3 years
Interventions
WMTother
Washed microbiota transplantation refers to the infusion of washed microbiota from healthy donor into patients' gastrointestinal tract. Participants will receive one dose of WMT for CDI. During follow-up, those who have non-response or CDI recurrence within 4-week post-WMT will receive rescue WMT.